Drug Profile
YS ON 001
Alternative Names: PIKA YS-ON-001; Polyinosinic-polycytidylic acid/inactivated rabies virus; Yivyka; YS-ON-001Latest Information Update: 25 Jan 2024
Price :
$50
*
At a glance
- Originator Yisheng Biopharma
- Developer YS Biopharma
- Class Antineoplastics; Cancer vaccines
- Mechanism of Action B cell stimulants; Cytokine stimulants; Dendritic cell stimulants; Immunostimulants; Macrophage modulators; Natural killer cell stimulants; Regulatory T lymphocyte inhibitors; Th1 cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Solid tumours